A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients

Clinical trial NCT00098007 · COMPLETED

Trial details

NCT number: NCT00098007
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Transplantation

Start date: 2004-08-09
Primary completion: 2007-01-08
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.